OMA Informs Regarding Share Trading Volume Today

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
OMA Informs Regarding Share Trading Volume Today

MONTERREY, Mexico, Jan. 15, 2016 (GLOBE NEWSWIRE) -- Mexican airport operator Grupo Aeroportuario del Centro Norte, S.A.B. de C.V., known as OMA (NASDAQ: OMAB ) (BMV: OMA ), informs that the trading volume of its shares on the Mexican Stock Exchange (BMV) exceeded normal ranges today principally as the result of an operation carried out by Banco Santander (México), S.A. (Santander), which exercised its right to sell 3.7 million Series B shares of OMA, which represent 0.9% of the OMA’s shares.  These shares were involved in an equity swap agreement between Aeroinvest, S.A. de C.V (a subsidiary of Empresas ICA) and Santander.

OMA reaffirms its commitment to inform the market on a timely basis of material events.

This press release may contain forward-looking information and statements. Forward-looking statements are statements that are not historical facts. These statements are only predictions based on our current information and expectations and projections about future events. Forward-looking statements may be identified by the words “believe,” “expect,” “anticipate,” “target,” “estimate,” or similar expressions. While OMA's management believes that the expectations reflected in such forward-looking statements are reasonable, investors are cautioned that forward-looking information and statements are subject to various risks and uncertainties, many of which are difficult to predict and are generally beyond the control of OMA, that could cause actual results and developments to differ materially from those expressed in, or implied or projected by, the forward-looking information and statements. These risks and uncertainties include, but are not limited to, those discussed in our most recent annual report filed on Form 20-F under the caption “Risk Factors.” OMA undertakes no obligation to update publicly its forward-looking statements, whether as a result of new information, future events, or otherwise.

About OMA

Grupo Aeroportuario del Centro Norte, S.A.B. de C.V., known as OMA, operates 13 international airports in nine states of central and northern Mexico. OMA’s airports serve Monterrey, Mexico’s third largest metropolitan area, the tourist destinations of Acapulco, Mazatlán, and Zihuatanejo, and nine other regional centers and border cities. OMA also operates a hotel inside Terminal 2 of the Mexico City airport. OMA employs over 1,000 persons in order to offer passengers and clients airport and commercial services in facilities that comply with all applicable international safety, security standards, and ISO 9001:2008. OMA’s strategic shareholder members are ICA, Mexico’s largest engineering, procurement, and construction company, and Aéroports de Paris Management, subsidiary of Aéroports de Paris, the second largest European airports operator. OMA is listed on the Mexican Stock Exchange (OMA) and on the NASDAQ Global Select Market (OMAB). For more information, visit

CONTACT: Chief Financial Officer Vicsaly Torres Ruiz +52 (81) 8625 4300 vtorres@oma.aero Investor Relations In Mexico Luis Emmanuel Camacho Thierry +52 (81) 8625 4308 ecamacho@oma.aero Manuel Higinio de Leon Diaz +52 (81) 8625 4334 mdeleon@oma.aero In the United States: Daniel Wilson / Zemi Communications +1 (212) 689 9560 dbmwilson@zemi.com Media Relations: Paola Fernandez +52 (81) 8625 4300 pfernandez@oma.aero

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 627

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 364

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
Fibocom LTE Modules Test Drive Satellite Connectivity

Updated Category News Views 153

Boosting IoT with Satellite Connectivity Here's a good one for folks watching the edge of wireless innovation. Fibocom's LTE Cat.1 bis modules, the LE270-EU and LE271-GL, just stretched their legs in New Zealand, connecting seamlessly with SpaceX's Direct to Cell (DTC) satellite system. No fancy hardware swaps, just standard firmware strutting its stuff across satellite...

Continue Reading
Cultural Tech Fusion: The Asia-Pacific Way Forward

Updated Category News Views 64

A High-Tech Twist on Traditional Culture You ever walk into a room and see a robot perform kung fu? I'll admit, it caught me off guard at first. But that's exactly what happened at the "Enduring Heritage, Harmonious Asia-Pacific" special exhibition in Shenzhen. With all the usual high-ranking execs and cultural bigwigs there, nobody expected a showcase where Wing Chun...

Continue Reading
Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 257

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
Fibocom Unveils U6G Solutions Advancing Global 5G Tech

Updated Category News Views 35

Breaking Barriers with U6G-Capable Technology Sneaking into the industry's spotlight at MWC Doha 2026, Fibocom flaunts a robust lineup of next-gen 5G solutions. It's as if they're shuffling every card they’ve got to win over the broadband world. With breakthroughs like the FG390, FG370, and FG670 modules, alongside PCBA-level innovations, Fibocom is not just throwing...

Continue Reading
ASMAX Unleashes Next-Level Motorcycle Comms at EICMA

Updated Category News Views 50

Transforming the Motorcycle Communication Landscape Motorcycling ain't just about the roaring engines and the rubber on the road. In the world of helmets and handlebars, some bright minds are weaving tech magic at the EICMA 2026 in Milan. ASMAX has rolled out its shiny new RoamX intercom gadget, leaving folks buzzing at Hall 6. What RoamX Brings to the Table This ain't...

Continue Reading
Stavian Group Eyes AI-Driven Southeast Asia Growth

Updated Category News Views 85

AI and Infrastructure: A New Chapter for Southeast Asia What does Southeast Asia's future look like with AI steering the ship? Well, there's a fresh breeze of change blowing, and right at the heart of it stands Stavian Group. At the recently held inaugural Fortune SEA500 Summit in Ho Chi Minh City, this conglomerate threw its hat into the ring, painting a vision of growth...

Continue Reading
Wuliangye Aims for Global Branding Boost at Panda Event

Updated Category News Views 52

Wuliangye Takes Center Stage at Global Event Everyone's chasing that global branding magic, but here's Wuliangye strutting its stuff at the Global Panda Partners Conference. Held in Sichuan Province from November 2 to 4, this is not just another show; it's a bold move from the Chinese baijiu maker to push the 'harmony and coexistence' mantra on the world stage. Not just...

Continue Reading
CureGene's Evategrel Aims for Breakthrough in Stroke Care

Updated Category News Views 110

Revolutionizing Stroke Care: Enter Evategrel When it comes to strokes, time is money—and I'm telling you, this ain't an area where you can afford to twiddle your thumbs. The faster you can get that blood flowing again, the better the chance you've got of walking away with less damage. That's where CureGene's new investigational drug, Evategrel, comes in. Why Evategrel...

Continue Reading

Top 5 Most Recently Viewed Articles

DESRI Completes Major Financing for Texas Solar Projects

Updated Category News Views 324

DESRI Completes Major Financing for Texas Solar Projects Today, DESRI proudly announced that it has closed a significant preferred equity financing of $129 million aimed at a 250-megawatt (MWac) solar development portfolio. This portfolio consists of two innovative solar projects located in West Texas, an area ripe for renewable energy enhancement. Meeting Industrial...

Continue Reading
Colossal Foundation Invests $500,000 in Condor Restoration Efforts

Updated Category News Views 76

Colossal Foundation Invests in Wildlife Recovery The Colossal Foundation has made a significant commitment of $500,000 towards restoring the California condor to its ancestral skies. This incredible movement represents a decade-long partnership with the Nez Perce Tribe, focusing on the recovery and reintroduction of North America’s largest land bird. For more than a...

Continue Reading
Revolutionary Self-Healing Film: The Future of Waterproofing

Updated Category News Views 108

Revolutionary Waterproofing Solutions by Charter Next Generation Charter Next Generation (CNG) recently unveiled its groundbreaking Nail Sealable film technology, designed to transform waterproofing in the construction industry. This pioneering self-healing film stands out with its exceptional moisture resistance and remarkable durability, making it a game changer for...

Continue Reading
Sonnet BioTherapeutics Provides Positive Safety Insights on SON-1010

Updated Category News Views 273

Exciting Safety Data from Sonnet BioTherapeutics’ SON-1010 Trial Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) has unveiled impressive topline safety data following a successful dose escalation of SON-1010 in the Phase 1 SB101 clinical trial. The study focused on the administration of SON-1010 to patients suffering from advanced solid tumors, marking a significant...

Continue Reading
Key Legal Information for Symbotic Inc. Shareholders

Updated Category News Views 73

Important Information for Symbotic Inc. Investors Recent developments surrounding Symbotic Inc. have captured the attention of investors globally. Investors who are shareholders of Symbotic Inc. (NASDAQ: SYM) may need to be aware of significant deadlines regarding a recent securities class action lawsuit. Overview of the Lawsuit Investors are reminded that they may have...

Continue Reading